Literature DB >> 22554789

Properties of end-stage human T cells defined by CD45RA re-expression.

Sian M Henson1, Natalie E Riddell, Arne N Akbar.   

Abstract

Persistent viral infections, inflammatory syndromes and ageing all induce the accumulation of highly differentiated CD45RA re-expressing memory T cells. These cells increase during ageing, especially in individuals who are infected with cytomegalovirus (CMV). These cells have decreased proliferative capacity, increased activation of senescence signalling pathways and greater susceptibility to apoptosis in vitro. However these cells are capable of multiple effector functions and thus bear all the hallmarks of short-lived effector T cells. This indicates that senescence signalling may govern the unique characteristics of effector T cells. In this article, we address the functional and migratory properties of these T cells and mechanisms that are involved in their generation. Finally we assess the potential for manipulation of their activity and whether this may improve immune function during ageing.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22554789     DOI: 10.1016/j.coi.2012.04.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  56 in total

1.  α-Fetoprotein Influence on the Conversion of Naïve T-Helpers into Memory T-Cell Effector Subpopulations.

Authors:  S A Zamorina; V P Timganova; M S Bochkova; P V Khramtsov; K A Fomicheva; M B Rayev; V A Chereshnev
Journal:  Dokl Biol Sci       Date:  2018-11-06

2.  Elevated double negative T cells in pediatric autoimmunity.

Authors:  James A Tarbox; Molly P Keppel; Nermina Topcagic; Charles Mackin; Miriam Ben Abdallah; Kevin W Baszis; Andrew J White; Anthony R French; Megan A Cooper
Journal:  J Clin Immunol       Date:  2014-04-24       Impact factor: 8.317

3.  Human blood Tfr cells are indicators of ongoing humoral activity not fully licensed with suppressive function.

Authors:  Valter R Fonseca; Ana Agua-Doce; Ana Raquel Maceiras; Wim Pierson; Filipa Ribeiro; Vasco C Romão; Ana Rita Pires; Susana Lopes da Silva; João Eurico Fonseca; Ana E Sousa; Michelle A Linterman; Luis Graca
Journal:  Sci Immunol       Date:  2017-08-11

4.  Development of an anti-CD45RA-quantum dots conjugated scFv to detect leukemic cancer stem cells.

Authors:  Shima Moradi-Kalbolandi; Fariba Dashtestani; Malihe Salehi; Neda Jalili; Keivan Majidzadeh-A; Reza Rahighi; Amir Yadegari; Leila Farahmand
Journal:  Mol Biol Rep       Date:  2019-10-22       Impact factor: 2.316

Review 5.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

Review 6.  Regulatory T cell memory.

Authors:  Michael D Rosenblum; Sing Sing Way; Abul K Abbas
Journal:  Nat Rev Immunol       Date:  2015-12-21       Impact factor: 53.106

Review 7.  Successful and Maladaptive T Cell Aging.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Immunity       Date:  2017-03-21       Impact factor: 31.745

8.  Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer.

Authors:  Christopher S Nabel; Mariano Severgnini; Yin P Hung; Amy Cunningham-Bussel; Evisa Gjini; Katja Kleinsteuber; Lake J Seymour; Martha K Holland; Rachel Cunningham; Kristin D Felt; Marina Vivero; Scott J Rodig; Elena M Massarotti; Osama E Rahma; Lauren C Harshman
Journal:  Oncologist       Date:  2019-05-14

Review 9.  T cell senescence and cardiovascular diseases.

Authors:  Hee Tae Yu; Sungha Park; Eui-Cheol Shin; Won-Woo Lee
Journal:  Clin Exp Med       Date:  2015-07-19       Impact factor: 3.984

10.  GATA3 induces mitochondrial biogenesis in primary human CD4+ T cells during DNA damage.

Authors:  Lauren A Callender; Johannes Schroth; Elizabeth C Carroll; Conor Garrod-Ketchley; Lisa E L Romano; Eleanor Hendy; Audrey Kelly; Paul Lavender; Arne N Akbar; J Paul Chapple; Sian M Henson
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.